Activation of coagulation and fibrinolysis in HIV-infected patients

被引:2
作者
Toulon, P
Gris, JC
Candia, N
Salmon, D
Sereni, D
Sicard, D
Schved, JF
机构
[1] HOP COCHIN,DEPT MED INTERNE,F-75679 PARIS 14,FRANCE
[2] CHRU NIMES,HEMATOL LAB,NIMES,FRANCE
关键词
D O I
10.1016/S0268-9499(96)80051-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Various coagulation abnormalities were reported in HIV-infected patients, which were usually considered as risk factors for thrombosis in the general population or in other disease states. This study was undertaken to determine whether HIV-infection was associated with an on-going pre/prothrombotic state, For that purpose, 70 consecutive HIV-infected out-patients were evaluated at distance of any acute episode, (55 males and 15 females with a mean age of 34 years,range: 19-69). 29 patients (41%) with a CD4+ lymphocytes count below 200 x 1O(6)/L were classified as having AIDS. The control group consisted of 33 age and sex-matched healthy individuals, The plasma levels of sensitive markers of thrombin generation (prothrombin fragment 1 + 2 and thrombin-antithrombin complex), plasmin generation (plasmin-plasmin inhibitor complex), and plasmin activity (fibrin degradation products) were measured using ELISAs. The plasma level of these markers were significantly higher in HIV-injected patients than in healthy HIV-negative controls, Moreover, the plasma levels of these markers were found to be highly significantly correlated (p < 0.001) in the patients group, suggesting an increased activation of both coagulation and fibrinolysis. However, despite trends toward increasing levels with decreasing CD4+ lymphocyte count, the plasma levels of these markers were not significantly different in AIDS and in non AIDS patients (classified upon the CD4+ lymphocytes count below and above 200 x 10(6)/L), These results suggest that HIV-infection is associated with an activation of both the coagulation and fibrinolytic systems, which could lead to a prothrombotic state in some of the patients.
引用
收藏
页码:59 / 61
页数:3
相关论文
共 17 条
[1]   INFLUENCE OF ANTICOAGULANTS USED FOR BLOOD COLLECTION ON PLASMA PROTHROMBIN FRAGMENT F1+2 MEASUREMENTS [J].
BAUER, KA ;
BARZEGAR, S ;
ROSENBERG, RD .
THROMBOSIS RESEARCH, 1991, 63 (06) :617-628
[2]  
BAUER KA, 1994, HAEMOSTASIS THROMBOS, P1189
[3]  
*CDC US DEP HHS, 1985, MMWR-MORBID MORTAL W, V34, P372
[4]  
[Anonymous], 1992, MMWR Recomm Rep, V41, P1
[5]   CIRCULATING COAGULATION INHIBITORS IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
COHEN, AJ ;
PHILIPS, TM ;
KESSLER, CM .
ANNALS OF INTERNAL MEDICINE, 1986, 104 (02) :175-180
[6]  
COHEN JR, 1990, NEW YORK STATE J MED, V90, P159
[7]   ALBUMIN CONCENTRATION INFLUENCES FIBRINOLYTIC-ACTIVITY IN PLASMA AND PURIFIED SYSTEMS [J].
GANDRILLE, S ;
AIACH, M .
FIBRINOLYSIS, 1990, 4 (04) :225-232
[8]  
KOPPERT PW, 1988, THROMB HAEMOSTASIS, V59, P310
[9]  
LAFEUILLADE A, 1991, NEW ENGL J MED, V324, P1220
[10]   INFLUENCE OF CONDITIONS OF BLOOD-SAMPLING ON COAGULATION ACTIVATION MARKERS (PROTHROMBIN FRAGMENT 1+2, THROMBIN-ANTITHROMBIN COMPLEXES AND D-DIMERS) MEASUREMENTS [J].
LEROYMATHERON, C ;
GOUAULTHEILMANN, M .
THROMBOSIS RESEARCH, 1994, 74 (04) :399-407